Abstract: The present invention is related to a M. tuberculosis fusion protein, polynucleotide coding for said protein, and a vector and host cell that contain said polynucleotide. The present invention also involves the preparation of said fusion protein, and the use thereof in preventions and treatment of tuberculosis.
Type:
Grant
Filed:
April 13, 2012
Date of Patent:
May 21, 2013
Assignees:
The 309th Hospital, The People's Liberation Army, Yangzhou Yilin Biotechnology Co., Ltd
Inventors:
Xiuyun He, Yuhui Zhuang, Haibin Wang, Jianhua Tao
Abstract: The present invention is related to a M. tuberculosis fusion protein, polynucleotide coding for said protein, and a vector and host cell that contain said polynucleotide. The present invention also involves the preparation of said fusion protein, and the use thereof in preventions and treatment of tuberculosis.
Type:
Application
Filed:
April 13, 2012
Publication date:
October 11, 2012
Applicants:
YANGZHOU YILIN BIOTECHNOLOGY CO., LTD, THE 309TH HOSPITAL, THE PEOPLE'S LIBERATION ARMY
Inventors:
Xiuyun HE, Yuhui ZHUANG, Haibin WANG, Jianhua TAO
Abstract: The present invention is related to a M. tuberculosis fusion protein, polynucleotide coding for said protein, and a vector and host cell that contain said polynucleotide. The present invention also involves the preparation of said fusion protein, and the use thereof in preventions and treatment of tuberculosis.
Type:
Grant
Filed:
January 10, 2007
Date of Patent:
May 8, 2012
Assignees:
The 309th Hospital, the People's Liberation Army, Yangzhou Yilin Biotechnology Co., Ltd
Inventors:
Xiuyun He, Yuhui Zhuang, Haibin Wang, Jianhua Tao